Apyx Medical Corporation (APYX)
NASDAQ:APYX
APYX Stock Chart & Stats
$3.13
-$0.11(-6.43%)
At close: 4:00 PM EST
$3.13
-$0.11(-6.43%)
Day’s Range― - ―
52-Week Range$0.76 - $4.50
Previous CloseN/A
Volume28.06K
Average Volume (3M)120.72K
Market Cap
$160.62M
Enterprise Value$159.86M
Total Cash (Recent Filing)$31.74M
Total Debt (Recent Filing)$39.34M
Price to Earnings (P/E)―
Beta2.18
Next Earnings
May 07, 2026EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding41,829,227
10 Day Avg. Volume65,017
30 Day Avg. Volume120,723
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)10.15
Price to Sales (P/S)2.79
P/FCF Ratio-16.19
Enterprise Value/Market Cap1.00
Enterprise Value/Revenue3.03
Enterprise Value/Gross Profit8.40
Enterprise Value/Ebitda-32.80
Forecast
1Y Price Target
$6.00Price Target Upside91.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.33
Revenue Forecast (FY)$57.95M
Bulls Say, Bears Say
Bulls Say
Addressable Market ExpansionGrowing patient demand for skin tightening tied to GLP-1 medication use expands the addressable market and creates new demand drivers for surgical skin tightening specialists.
Commercial TractionStrong U.S. demand for the Ayon device is driving commercial traction in the surgical aesthetics business, increasing surgeon interest and supporting revenue growth.
Profitability ImprovementTransition into adjusted EBITDA profitability following restructuring indicates effective expense control and sufficient cash resources to support progress toward sustainable operating profitability.
Bears Say
Channel Cannibalization RiskDecline in domestic generator upgrades as sales representatives prioritize promoting Ayon may reduce aftermarket upgrade revenue and slow replacement cycles for existing systems.
OEM Segment WeaknessWeaker-than-expected OEM business is pressuring the overall sales mix and could undermine near-term revenue resilience.
Apyx Medical News
APYX FAQ
What was Apyx Medical Corporation’s price range in the past 12 months?
Apyx Medical Corporation lowest stock price was $0.76 and its highest was $4.50 in the past 12 months.
What is Apyx Medical Corporation’s market cap?
Apyx Medical Corporation’s market cap is $160.62M.
When is Apyx Medical Corporation’s upcoming earnings report date?
Apyx Medical Corporation’s upcoming earnings report date is May 07, 2026 which is in 40 days.
How were Apyx Medical Corporation’s earnings last quarter?
Apyx Medical Corporation released its earnings results on Mar 10, 2026. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.055 by $0.025.
Is Apyx Medical Corporation overvalued?
According to Wall Street analysts Apyx Medical Corporation’s price is currently Undervalued.
Does Apyx Medical Corporation pay dividends?
Apyx Medical Corporation does not currently pay dividends.
What is Apyx Medical Corporation’s EPS estimate?
Apyx Medical Corporation’s EPS estimate is -0.11.
How many shares outstanding does Apyx Medical Corporation have?
Apyx Medical Corporation has 41,829,227 shares outstanding.
What happened to Apyx Medical Corporation’s price movement after its last earnings report?
Apyx Medical Corporation reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.055. Following the earnings report the stock price went up 0.583%.
Which hedge fund is a major shareholder of Apyx Medical Corporation?
Currently, no hedge funds are holding shares in APYX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Apyx Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.00 (91.69% Upside)
$6.00 (91.69% Upside)
Hedge Fund Trend
Decreased
By 181.4K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
129.93%
12-Months-Change
Fundamentals
Return on Equity
-117.54%
Trailing 12-Months
Asset Growth
3.08%
Trailing 12-Months
Company Description
Apyx Medical Corporation
Apyx Medical Corporation (NASDAQ: APYX) is a medical technology company specializing in the development and commercialization of innovative surgical products. The company focuses on two main sectors: surgical energy and cosmetic dermatology. Apyx Medical's core product offerings include the Renuvion® technology, which utilizes helium plasma for skin rejuvenation and various surgical applications, as well as a range of devices designed for energy-based surgical procedures aimed at improving patient outcomes.
APYX Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong focus on the successful launch and market acceptance of the AYON Body Contouring System, with substantial revenue growth in the Surgical Aesthetics segment. Despite declines in OEM revenue and international sales, the company's strategic focus on AYON and improved financial health contribute to a positive outlook.View all APYX earnings summariesAPYX Stock 12 Month Forecast
Average Price Target
$6.00
▲(91.69% Upside)
Technical Analysis
Ownership Overview
1.54% Insiders
7.78% Mutual Funds
34.03% Other Institutional Investors
52.97% Public Companies and
Individual Investors